(p-ClPhSe)2 Reduces Hepatotoxicity Induced by Monosodium Glutamate by Improving Mitochondrial Function in Rats

Caroline B Quines1, Pietro M Chagas1, Diane Hartmann2

  • 1Laboratório de Síntese, Reatividade e Avaliação Farmacológica e Toxicológica de Organocalcogênios, Centro de Ciências Naturais e Exatas, Departamento de Bioquímica e Biologia Molecular, Universidade Federal de Santa Maria, Santa Maria, CEP 97105-900, RS, Brazil.

Insights

Organic selenium compounds, like p-chloro-diphenyl diselenide, show promise in combating obesity-related liver damage. This study found it protected rats from liver injury caused by monosodium glutamate, reducing oxidative stress and inflammation.

Area of Science:

  • Biochemistry
  • Toxicology
  • Pharmacology

Background:

  • Morbid obesity is linked to mitochondrial dysfunction, oxidative stress, and chronic inflammation.
  • Organic selenium compounds possess antioxidant, anti-inflammatory, and antihyperglycemic properties.
  • Developing safe and effective anti-obesity drugs is a significant research focus.

Purpose of the Study:

  • To investigate the hepatoprotective effects of p-chloro-diphenyl diselenide ((p-ClPhSe)2) in a rat model of monosodium glutamate (MSG)-induced obesity.
  • To assess the impact of (p-ClPhSe)2 on mitochondrial function, oxidative stress, and inflammatory markers in the liver.

Main Methods:

  • Wistar rats were administered MSG during the early postnatal period to induce obesity.
  • (p-ClPhSe)2 was administered intragastrically to rats from day 90 to 97 post-birth.
  • Liver tissues were analyzed for mitochondrial function, purine content, and levels of apoptosis (PARP) and inflammation (iNOS, p38) related proteins.

Main Results:

  • MSG administration induced mitochondrial dysfunction, oxidative stress, and increased ADP levels in rat livers.
  • MSG treatment led to hepatotoxicity, evidenced by elevated levels of PARP, iNOS, and p38.
  • (p-ClPhSe)2 treatment mitigated mitochondrial dysfunction, reduced oxidative stress, and modulated apoptosis and inflammation markers in MSG-treated rats.

Conclusions:

  • Postnatal MSG administration causes significant liver damage, including mitochondrial dysfunction and inflammation, in adult rats.
  • (p-ClPhSe)2 demonstrates notable hepatoprotective effects against MSG-induced liver injury.
  • Organic selenium compounds like (p-ClPhSe)2 represent a potential therapeutic strategy for managing obesity-related liver complications.

Related Concept Videos

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
1.1K
Phase II Reactions: Miscellaneous Conjugation Reactions01:19

Phase II Reactions: Miscellaneous Conjugation Reactions

Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
428
Drug Metabolism: Phase I Reactions01:17

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
5.4K
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
841
Phase I Reactions: Reductive Reactions01:27

Phase I Reactions: Reductive Reactions

Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
687
Phase I Oxidative Reactions: Overview01:19

Phase I Oxidative Reactions: Overview

Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
916